1. Trial design is finalized but not locations. My guess sites waiting for IND approval before commitment can be finalized. Still impressive list of sites.
2. # of patients may be less if results are extremely successful and thus trial could be ended early and PMCB applies for accelerated approval.
Lol because pmcb is nothing but a share selling scam. Legit biotechs work with or at least in contact with the FDA on setting up trial designs. They don't put out a pr. everytime they sharpen their pencils. Pmcb is just milking investors along as long as possible.
Market Data 
Markets 
AI
